Key Insights

Highlights

Treatment Research

3 treatments under study, led by Minipcnl

Research Leaders

18 sponsors active, led by New Mowasat Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Minipcnl1
  • Smp1
  • Standardpcnl1

Active Sponsors

  • New Mowasat Hospital1
  • Mt. Carmel Diocesan General Hospital1
  • University Hospital of Vinalopo1
  • University of Belgrade1
  • Vayodha and Venus International Hospitals1

Top Investigators

Related Conditions

  • Surgery1
  • Stone Kidney1

Activity Timeline